Ignite International Brands, Ltd. (CSE:BILZ, OTCQX:BILZF) (“IGNITE” or the “Company”) announces today that it is continuing with its plans to expand its distribution, both domestically (within North America) and internationally, in addition to introducing new products in fiscal 2020.
The Company is pleased to confirm that it has entered into agreements with two leading US companies; Acosta, Inc. (“Acosta”) and Accelerate 360 (“Accelerate”).
Acosta is a leading full-service sales and marketing agency in the consumer-packaged goods industry, and pursuant to the terms of the agreement, will use its vast resources to support the Company in a broad spectrum of capabilities with its deep experience and connections. The Company views Acosta as a sales and marketing powerhouse behind some of the world’s most recognized brands and a proven resource for top retailers across the United States and Canada. Pursuant to the agreement, IGNITE will tap into Acosta’s 100+ offices across the United States and Canada to reach 200,000+ outlet visits each month.
Accelerate provides a complete CBD solution for retail partners from program management to distribution and merchandising. Accelerate distributes some of largest and most prestigious CBD brands in the United States with a wide range of products that are regularly tested in reputable and independent labs. IGNITE understands that Accelerate is committed to delivering the right products to the right place at the right time. The Company’s view is that Accelerate combines an experienced staff with cutting-edge technology and data analytics to execute at the highest levels in the industry.
“We are building IGNITE to be a global brand, with innovative, quality products and expanded domestic and international distribution as our highest priority,” said President, Curtis Heffernan. “The new strategic partnerships with Acosta and Accelerate will help IGNITE reach more consumers through new points of distribution for our recently expanded product portfolio.”
During fiscal 2020, the super-premium IGNITE brand plans to announce new product lines, including beverages and an expanded apparel line. These value-added additions will supplement the current line of expanded CBD product offerings, including those introduced in November and December of 2019 which included broad spectrum and isolate gummies, broad spectrum and full spectrum drops, bath bombs, roll-ons, lip balms, sports creams, and an exciting new line of CBD pet products including drops (peanut butter and natural), coat spray, hot spot cream, and soft chew treats.
IGNITE now also offers broad spectrum CBG drops and full spectrum CBN drops. CBG (cannabigerol) is a cannabinoid found in hemp plants that is similar to CBD, but more uplifting. CBN (cannabinol) is a cannabinoid found in hemp plants that is similar to CBD, but more calming. As with other extracts, these drops contain multiple cannabinoids along with a proprietary terpene blend. The combination of these plant compounds magnifies the cannabinoids through an entourage effect.
Please visit www.ignitecbd.co to learn more about the full line of IGNITE’s premium products.
For more information about Acosta, please visit www.acosta.com.
For more information about Accelerate, please visit www.accelerate360.com.
IGNITE is a CSE-listed and OTCQX traded company operating in permissible CBD and cannabis sectors in addition to other product categories. IGNITE intends to expand its business, which currently includes branding, marketing, licensing, sales and distribution, across the United States, Canada, the United Kingdom and Mexico by leveraging multiple product platforms. The Company intends to affect this expansion through brand leverage, product development, targeted marketing and strategic supply chain partnerships in each of its active and target jurisdictions.
For further information, please contact:
IGNITE Investor Relations
Cautionary Statement Regarding Forward-Looking Information
This news release includes certain “forward-looking statements” under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to IGNITE’s plans for 2020, including the expected results of the relationships with Acosta and Accelerate, and the overall success of the current and new product offerings. Forward-looking statements are necessarily based upon several estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties; ability of IGNITE to give effect to its business plan; reliance on the “IGNITE” brand which may not prove to be as successful as contemplated; the ability to and risks associated with unlocking future licensing opportunities with the “IGNITE” brand, building a global CBD and cannabis brand and the ability of IGNITE to capture significant market share; and the uncertainties surrounding the CBD and cannabis industries in North America and internationally. There can be no assurance that any of the forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether because of new information, future events or otherwise, except as required by law.
In the evolving rush of mergers and acquisitions (M&A) in the Canadian cannabis market, Canopy Growth (NASDAQ:CGC,TSX:WEED) announced it will acquire The Supreme Cannabis Company (TSX:FIRE,OTCQX:SPRWF) in a deal worth approximately C$435 million.
Meanwhile, a cannabis operator in the US confirmed this week that it will receive a financial boost from a partner to solidify its position in the burgeoning Pennsylvania state market.
The Board of Directors of Aphria Unanimously Recommends Shareholders Vote “For” the Arrangement
Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021 to Approve Proposed Aphria-Tilray Business Combination
Love Hemp Group PLC (AQSE: LIFE) (OTCQB: WRHLF), one of the UK’s leading CBD and Hemp product suppliers, announces that as part of the equity fundraise announced yesterday, Antony Calamita and Andrew Male, Directors of the Company, subscribed for 285,714 Ordinary Shares and 1,428,571 Ordinary Shares respectively. The subscriptions are at a price of 3.5 pence per ordinary share for a total of £60,000. Following these subscriptions, Antony Calamita is now interested in 54,385,714 Ordinary Shares, representing 8.61% of the Company’s share capital as increased by the fundraising, and Andrew Male is now interested in 6,138,196 Ordinary Shares, representing 0.97% of the Company’s issued share capital as increased by the fundraising
Further, the timetable for receipt of applications under the Broker Option, which was also announced yesterday, has been extended until 5:00 pm 9 April 2021 to capture additional interest which was unable to be completed yesterday.
Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, would like to provide the following dial-in information for the Company’s upcoming Annual and Special Meeting (the “Meeting”) scheduled to be held at 11:00 a.m. Eastern Daylight Time on April 12, 2021. Shareholders and proxyholders may access the Meeting via teleconference by dialing 647-723-3984 or 1-866-365-4406 from Canada or the United States, then entering participation code “8487744” followed by the pound (“#”) sign.
In consideration of the COVID-19 pandemic and the recent restrictions imposed by the Ontario Provincial Government, shareholders and proxyholders will only be able to attend the Meeting via teleconference and will not be permitted to attend the Meeting in person at the address provided on the Notice of Annual and Special Meeting of Shareholders.
Gage Cannabis Announces Exclusive Partnership With Blue River to Bring Award-Winning Cannabis Extracts to Michigan
Gage Growth Corp. (“Gage” or the “Company”) (CSE:GAGE), a leading high-quality craft cannabis brand and operator in Michigan, announced today that it has signed an agreement with Blue River™ Extracts & Terpenes (“Blue River™”) to bring the brand’s award-winning solventless technology and other trademark branded products to the state’s medical patients and cannabis consumers. The Company will have exclusive rights to Blue River™’s premium product offerings in Michigan.